Jennifer R Krumrine1, Andrew T Maynard, Charles L Lerman
1Computational Chemistry & Informatics, Department of Chemistry, AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, Delaware 19850-5437, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study introduces two statistical methods to improve virtual screening (VS) by prioritizing potential drug leads and reducing large compound databases. These techniques enhance the efficiency of identifying promising compounds for experimental testing.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: